Sara Bonstein - Net Worth and Insider Trading

Sara Bonstein Net Worth

The estimated net worth of Sara Bonstein is at least $8 Million dollars as of 2024-11-05. Sara Bonstein is the CFO of Insmed Inc and owns about 117,481 shares of Insmed Inc (INSM) stock worth over $8 Million. Sara Bonstein is the CFO of Advaxis Inc and owns about 187 shares of Advaxis Inc (ADXS) stock worth over $178. Sara Bonstein is also the CFO/COO of OncoSec Medical Inc and owns about 1,881 shares of OncoSec Medical Inc (ONCSQ) stock worth over $0. Details can be seen in Sara Bonstein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sara Bonstein has not made any transactions after 2024-05-29 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Sara Bonstein

To

Sara Bonstein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sara Bonstein owns 5 companies in total, including scPharmaceuticals Inc (SCPH) , Insmed Inc (INSM) , and OncoSec Medical Inc (ONCSQ) among others .

Click here to see the complete history of Sara Bonstein’s form 4 insider trades.

Insider Ownership Summary of Sara Bonstein

Ticker Comapny Transaction Date Type of Owner
SCPH scPharmaceuticals Inc 2020-07-08 director
INSM Insmed Inc 2024-05-29 Chief Financial Officer
ONCSQ OncoSec Medical Inc 2020-01-16 CFO/COO
LIMIT LIMIT 2018-01-03 Chief Financial Officer
LIMIT LIMIT 2021-10-21 director

Sara Bonstein Latest Holdings Summary

Sara Bonstein currently owns a total of 3 stocks. Among these stocks, Sara Bonstein owns 117,481 shares of Insmed Inc (INSM) as of May 29, 2024, with a value of $8 Million and a weighting of 100%. Sara Bonstein owns 187 shares of Advaxis Inc (ADXS) as of January 3, 2018, with a value of $178 and a weighting of 0%. Sara Bonstein also owns 1,881 shares of OncoSec Medical Inc (ONCSQ) as of January 16, 2020, with a value of $0 and a weighting of 0%.

Latest Holdings of Sara Bonstein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INSM Insmed Inc 2024-05-29 117,481 68.25 8,017,491
ADXS Advaxis Inc 2018-01-03 187 0.95 178
ONCSQ OncoSec Medical Inc 2020-01-16 1,881 0.00 0

Holding Weightings of Sara Bonstein


Sara Bonstein Form 4 Trading Tracker

According to the SEC Form 4 filings, Sara Bonstein has made a total of 8 transactions in Insmed Inc (INSM) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Insmed Inc is the sale of 241,288 shares on May 29, 2024, which brought Sara Bonstein around $12 Million.

According to the SEC Form 4 filings, Sara Bonstein has made a total of 0 transactions in Advaxis Inc (ADXS) over the past 5 years. The most-recent trade in Advaxis Inc is the sale of 4 shares on January 3, 2018, which brought Sara Bonstein around $16,612.

According to the SEC Form 4 filings, Sara Bonstein has made a total of 1 transactions in OncoSec Medical Inc (ONCSQ) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in OncoSec Medical Inc is the sale of 61 shares on January 16, 2020, which brought Sara Bonstein around $2,810.

Insider Trading History of Sara Bonstein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sara Bonstein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sara Bonstein Ownership Network

Ownership Network List of Sara Bonstein

No Data

Ownership Network Relation of Sara Bonstein

Insider Network Chart

Sara Bonstein Owned Company Details

What does scPharmaceuticals Inc do?

Who are the key executives at scPharmaceuticals Inc?

Sara Bonstein is the director of scPharmaceuticals Inc. Other key executives at scPharmaceuticals Inc include 10 percent owner Orbimed Advisors Llc , 10 percent owner 5am Partners Iv, Llc , and director & President and CEO John H Tucker .

scPharmaceuticals Inc (SCPH) Insider Trades Summary

Over the past 18 months, Sara Bonstein made no insider transaction in scPharmaceuticals Inc (SCPH). Other recent insider transactions involving scPharmaceuticals Inc (SCPH) include a net purchase of 500,000 shares made by Orbimed Advisors Llc ,

In summary, during the past 3 months, insiders sold 0 shares of scPharmaceuticals Inc (SCPH) in total and bought 500,000 shares, with a net purchase of 500,000 shares. During the past 18 months, 0 shares of scPharmaceuticals Inc (SCPH) were sold and 500,000 shares were bought by its insiders, resulting in a net purchase of 500,000 shares.

scPharmaceuticals Inc (SCPH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

scPharmaceuticals Inc Insider Transactions

No Available Data

Sara Bonstein Mailing Address

Above is the net worth, insider trading, and ownership report for Sara Bonstein. You might contact Sara Bonstein via mailing address: 305 College Road East, Princeton Nj 08540.